Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$0.37 - $0.72 $4,617 - $8,984
12,479 New
12,479 $8,000
Q1 2023

May 15, 2023

BUY
$1.16 - $6.41 $5,568 - $30,768
4,800 Added 8.89%
58,794 $68,000
Q4 2022

Feb 14, 2023

BUY
$4.78 - $15.01 $43,976 - $138,092
9,200 Added 20.54%
53,994 $285,000
Q3 2022

Nov 10, 2022

BUY
$10.22 - $23.7 $457,794 - $1.06 Million
44,794 New
44,794 $516,000

Others Institutions Holding VERU

About VERU INC.


  • Ticker VERU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,146,704
  • Market Cap $56.9M
  • Description
  • Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....
More about VERU
Track This Portfolio

Track Cetera Advisor Networks LLC Portfolio

Follow Cetera Advisor Networks LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Advisor Networks LLC with notifications on news.